12:00 AM
 | 
Jan 04, 2018
 |  BC Extra  |  Financial News

BioNTech raises $270M series A

Immuno-oncology company BioNTech AG (Mainz, Germany) raised $270 million in a series A round led by new investor Redmile Group. Other new investors included Janus Henderson Investors, Invus, Fidelity and several undisclosed European family offices. The Strüngmann family office, a founding investor of BioNTech and majority shareholder, also participated...

Read the full 223 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >